TM. Dando, LJ. Scott, Abacavir plus lamivudine: a review of their combined use in the management of HIV infection., in Drugs, vol. 65, n. 2, 2005, pp. 285-302, PMID 15631548.
H. Soudeyns, XI. Yao; Q. Gao; B. Belleau; JL. Kraus; N. Nguyen-Ba; B. Spira; MA. Wainberg, Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog., in Antimicrob Agents Chemother, vol. 35, n. 7, luglio 1991, pp. 1386-90, PMID 1929298.
JA. Coates, N. Cammack; HJ. Jenkinson; IM. Mutton; BA. Pearson; R. Storer; JM. Cameron; CR. Penn, The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro., in Antimicrob Agents Chemother, vol. 36, n. 1, gennaio 1992, pp. 202-5, PMID 1590690.
S. Kewn, GJ. Veal; PG. Hoggard; MG. Barry; DJ. Back, Lamivudine (3TC) phosphorylation and drug interactions in vitro., in Biochem Pharmacol, vol. 54, n. 5, settembre 1997, pp. 589-95, PMID 9337075.
SL. Doong, CH. Tsai; RF. Schinazi; DC. Liotta; YC. Cheng, Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues., in Proc Natl Acad Sci U S A, vol. 88, n. 19, ottobre 1991, pp. 8495-9, PMID 1656445.
MA. Johnson, KH. Moore; GJ. Yuen; A. Bye; GE. Pakes, Clinical pharmacokinetics of lamivudine., in Clin Pharmacokinet, vol. 36, n. 1, gennaio 1999, pp. 41-66, PMID 9989342.
GJ. Yuen, DM. Morris; PK. Mydlow; S. Haidar; ST. Hall; EK. Hussey, Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine., in J Clin Pharmacol, vol. 35, n. 12, dicembre 1995, pp. 1174-80, PMID 8750368.
AE. Heald, PH. Hsyu; GJ. Yuen; P. Robinson; P. Mydlow; JA. Bartlett, Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction., in Antimicrob Agents Chemother, vol. 40, n. 6, giugno 1996, pp. 1514-9, PMID 8726029.
CM. Perry, D. Faulds, Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection., in Drugs, vol. 53, n. 4, aprile 1997, pp. 657-80, PMID 9098665.
Joep Lange, Combination antiretroviral therapy. Back to the future., in Drugs, 49 Suppl 1, 1995, pp. 32-7; discussion 38-40, PMID 7614900.
SJ. Keam, LJ. Scott, Lamivudine: in children and adolescents with chronic hepatitis B virus infection., in Paediatr Drugs, vol. 4, n. 10, 2002, pp. 687-94; discussion 695-6, PMID 12269843.
Z. Fox, UB. Dragsted; J. Gerstoft; AN. Phillips; J. Kjaer; L. Mathiesen; M. Youle; C. Katlama; A. Hill; JN. Bruun; N. Clumeck, A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial., in Antivir Ther, vol. 11, n. 6, 2006, pp. 761-70, PMID 17310820.